Cereno Scientific AB (FRA:4A1) E10: €-0.06 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:4A1 Cereno Scientific AB FRA:4A1
39 GF Score
Price €0.43
! 3 Warning Signs
View Full Analysis

What is Cereno Scientific AB E10?

Cereno Scientific AB FRA:4A1 +4.69% 39 E10 is €-0.06 as of Mar. 2026. GuruFocus rates FRA:4A1 with a GF Score™ of 39/100. The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Cereno Scientific AB's adjusted earnings per share data for the three months ended in Mar. 2026 was €-0.008. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-0.06 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-08-02), Cereno Scientific AB's current stock price is €0.4288. Cereno Scientific AB's E10 for the quarter that ended in Mar. 2026 was €-0.06. Cereno Scientific AB's Shiller PE Ratio of today is .


Cereno Scientific AB  (FRA:4A1) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Cereno Scientific AB E10 Related Terms


Cereno Scientific AB E10 Historical Data

* Premium members only.

The historical data trend for Cereno Scientific AB's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cereno Scientific AB E10 Chart

Cereno Scientific AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -0.05

Cereno Scientific AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.05 -0.05 -0.05 -0.05 -0.06

FRA:4A1 vs ZTS: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Cereno Scientific AB's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cereno Scientific AB Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cereno Scientific AB's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Cereno Scientific AB's Shiller PE Ratio falls into.


FRA:4A1
39GF Score
Cereno Scientific AB FRA:4A1
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cereno Scientific AB E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Cereno Scientific AB's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.008/133.5600*133.5600
=-0.008

Current CPI (Mar. 2026) = 133.5600.

Cereno Scientific AB Quarterly Data

per share eps CPI Adj_EPS
201606 -0.032 101.019 -0.042
201609 -0.010 101.138 -0.013
201612 -0.009 102.022 -0.012
201703 -0.007 102.022 -0.009
201706 -0.010 102.752 -0.013
201709 -0.012 103.279 -0.016
201712 -0.014 103.793 -0.018
201803 -0.016 103.962 -0.021
201806 -0.027 104.875 -0.034
201809 -0.021 105.679 -0.027
201812 -0.020 105.912 -0.025
201903 -0.027 105.886 -0.034
201906 -0.011 106.742 -0.014
201909 -0.007 107.214 -0.009
201912 0.025 107.766 0.031
202003 -0.008 106.563 -0.010
202006 -0.010 107.498 -0.012
202009 -0.008 107.635 -0.010
202012 -0.007 108.296 -0.009
202103 -0.005 108.360 -0.006
202106 -0.007 108.928 -0.009
202109 -0.005 110.338 -0.006
202112 -0.004 112.486 -0.005
202203 -0.005 114.825 -0.006
202206 -0.006 118.384 -0.007
202209 -0.006 122.296 -0.007
202212 -0.008 126.365 -0.008
202303 -0.003 127.042 -0.003
202306 -0.004 129.407 -0.004
202309 -0.004 130.224 -0.004
202312 -0.008 131.912 -0.008
202403 -0.006 132.205 -0.006
202406 -0.081 132.716 -0.082
202409 -0.007 132.304 -0.007
202412 -0.012 132.987 -0.012
202503 -0.008 132.825 -0.008
202506 -0.008 133.699 -0.008
202509 -0.006 133.480 -0.006
202512 -0.013 133.390 -0.013
202603 -0.008 133.560 -0.008

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of €-0.06 mean?
Cereno Scientific AB (FRA:4A1) has a E10 of €-0.06 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Cereno Scientific AB and its competitors.
Is Cereno Scientific AB's E10 too high?
Cereno Scientific AB's current E10 is €-0.06. Overall, Cereno Scientific AB has a GF Score™ of 39/100, reflecting its overall financial health beyond just this single metric.
How does Cereno Scientific AB's E10 compare to ZTS?
Cereno Scientific AB's E10 of €-0.06 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Cereno Scientific AB and its competitors. Cereno Scientific AB's current E10 is €-0.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cereno Scientific AB stock overvalued right now?
Cereno Scientific AB (FRA:4A1) has a current E10 of €-0.06. The current E10 is €-0.06. Cereno Scientific AB's overall GF Score™ is 39/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Cereno Scientific AB (FRA:4A1), the current E10 is €-0.06 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cereno Scientific AB Business Description

Other Exchanges CRNO B:Sweden
Address Forandringens gata 10, Molndal, SWE, 431 53
Cereno Scientific AB is developing a pipeline of preventive therapeutics to treat cardiovascular and rare diseases by epigenetic modulation through histone deacetylase inhibition (HDACi). The company's program, CS1, is a phase two dual-acting antithrombotic drug aimed at venous thrombosis and stroke prevention for atrial fibrillation. It also evaluates the potential of epigenetic modulation for rare diseases related to pulmonary fibrosis, thrombosis, inflammation, and high blood pressure in the pulmonary circulation system.
39GF Score

Get the complete analysis for FRA:4A1

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.43
Price